Changing or stopping GLP-1 treatment
There is no universal taper schedule in the product information cited here. Plan any dose reduction or stop with your prescriber, including follow-up and support if appetite or weight changes.
Discussing a treatment change #
Talk through why you want to change treatment: side effects, cost, pregnancy plans, health changes or your preferences. Review your other medicines and any diabetes care. If you have a serious suspected reaction, follow the urgent advice in your leaflet rather than waiting to complete a taper.
What the evidence can tell us #
The SURMOUNT-4 and STEP 4 trials compared continuing treatment with switching to placebo. They show a risk of regain after withdrawal; they do not establish that a particular taper prevents it.
This page therefore does not prescribe a sequence of lower doses or a timetable for stopping. Any individual plan should explain its rationale, limitations and monitoring.
Medicine-specific considerations #
Do not assume that tablets leave the body faster than injections: the active medicine matters. Oral and injected semaglutide are both semaglutide. Do not switch formulations, take tablets on alternate days or stretch injection intervals without a prescribing decision. Pregnancy wash-out periods differ; see pregnancy and contraception.
Tell your prescriber how long you have been off treatment before restarting. Your previous dose may no longer be appropriate.
Support alongside a change #
Agree a realistic eating and activity plan, access to support, and review dates. Discuss how to monitor weight and health without increasing distress. Regain is a reason to review care, not evidence of personal failure. Continuing treatment may remain an appropriate option.
Continue reading
Understand your treatment options
Aero’s treatment prices and service inclusions will be confirmed before booking opens. Ask which prescribing, dispensing, delivery and follow-up costs are included in your quote.
Page information
- Summary
- What withdrawal trials can tell us, why they do not establish a universal taper, and how to plan a treatment change with your prescriber. Read more.
- Publisher
- Aero Clinic, operated by AERO HEALTHCARE LTD.
- Editorial update
- Clinical review
- Pending. An editorial update is not a clinical sign-off.
Cite as: Changing or stopping GLP-1 treatment, Aero Clinic (https://www.cagri.co.uk), AERO HEALTHCARE LTD. https://www.cagri.co.uk/tapering-off-glp1. Editorial update: 4 November 2026. Clinical review pending.